- Home
- CADL vs LFMD Comparison
CADL vs LFMD Comparison
Compare CADL & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- LFMD
- Stock Information
- Founded
- CADL 1999
- LFMD 1994
- Country
- CADL United States
- LFMD United States
- Employees
- CADL N/A
- LFMD N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- LFMD Medical/Nursing Services
- Sector
- CADL Health Care
- LFMD Health Care
- Exchange
- CADL Nasdaq
- LFMD Nasdaq
- Market Cap
- CADL 339.8M
- LFMD 330.5M
- IPO Year
- CADL 2021
- LFMD N/A
- Fundamental
- Price
- CADL $5.22
- LFMD $5.74
- Analyst Decision
- CADL Strong Buy
- LFMD Buy
- Analyst Count
- CADL 7
- LFMD 6
- Target Price
- CADL $19.57
- LFMD $12.50
- AVG Volume (30 Days)
- CADL 846.0K
- LFMD 766.8K
- Earning Date
- CADL 11-14-2025
- LFMD 11-06-2025
- Dividend Yield
- CADL N/A
- LFMD N/A
- EPS Growth
- CADL N/A
- LFMD N/A
- EPS
- CADL N/A
- LFMD N/A
- Revenue
- CADL N/A
- LFMD $245,563,670.00
- Revenue This Year
- CADL N/A
- LFMD $21.50
- Revenue Next Year
- CADL N/A
- LFMD $17.18
- P/E Ratio
- CADL N/A
- LFMD N/A
- Revenue Growth
- CADL N/A
- LFMD 37.74
- 52 Week Low
- CADL $3.79
- LFMD $4.13
- 52 Week High
- CADL $14.60
- LFMD $15.84
- Technical
- Relative Strength Index (RSI)
- CADL 44.00
- LFMD 35.61
- Support Level
- CADL $5.35
- LFMD $5.76
- Resistance Level
- CADL $5.80
- LFMD $6.44
- Average True Range (ATR)
- CADL 0.34
- LFMD 0.23
- MACD
- CADL -0.04
- LFMD -0.04
- Stochastic Oscillator
- CADL 9.49
- LFMD 6.02
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.